Related Experiment Video
Updated: Aug 12, 2025

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
Published on: December 9, 2016
Extraosseous Ewing Sarcoma in a Pelvic Region: A Case Report
Sushma Gurung1, Sagun Thapa1, Shristi Gautam1
1Department of Paediatric Haematology and Oncology, Bhaktapur Cancer Hospital, Dudhpati, Bhaktapur, Nepal.
Extraosseous Ewing sarcoma, a rare soft tissue tumor, can present in the pelvic region. Prompt diagnosis and multidisciplinary treatment, including chemotherapy, surgery, and radiotherapy, led to complete tumor resolution in a pediatric patient.
Area of Science:
- Oncology
- Pediatric Oncology
- Skeletal and Soft Tissue Tumors
Background:
- Ewing sarcoma is the second most common pediatric bone malignancy.
- Extraskeletal Ewing sarcoma is rare, with primary pelvic origin being exceptionally uncommon.
- This case highlights a rare presentation of extraskeletal Ewing sarcoma in the pelvic region.
Observation:
- A 17-year-old female presented with a progressive lower abdominal mass and pain.
- CT revealed a large pelvic lesion (12.9 x 9.8 x 9.3 cm).
- Biopsy confirmed a small round blue cell tumor with specific immunohistochemical markers (CD99, vimentin, FLI-1) and high proliferation (Ki-67 40%).
Findings:
- The patient received neoadjuvant chemotherapy, surgical resection, and radiotherapy.
- Complete tumor resolution was achieved following the comprehensive treatment regimen.
- Immunohistochemistry confirmed the diagnosis of Ewing sarcoma.
Implications:
- This case underscores that EES can occur in diverse soft tissue locations, including the pelvis.
- Distinguishing EES from other soft tissue sarcomas is crucial for appropriate management.
- Multimodal therapy (chemotherapy, surgery, radiotherapy) can lead to favorable prognoses in EES.
More Related Videos
05:52Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019